Menu

Kaleido Biosciences, Inc. KLDO

Full chart Compare
Set alert

Price alert · KLDO

All alert types
0.00 USD 0.00 (+0.00%)

At closeNov 6, 2026, 4:00 PM EST

0.0001 Day range 0.0001
0.00001 52-week range 0.20005
YTD
0.00%
1 year
0.00%

Revenue & Expenses

Other Income → Expenses: $217.00KExpenses → Selling, General & Admin: $20.97MExpenses → Research & Development: $67.80MExpenses → Interest Expense: $2.84MGross Profit → Expenses: $1.10MRevenue → Gross Profit: $1.10MNet Loss → Expenses: $90.29MOther Income$217.00KGross Profit$1.10MNet Loss$90.29MExpenses$91.61MSelling, General & Admin$20.97MResearch & Development$67.80MInterest Expense$2.84MRevenue$1.10M

Latest period ending Dec 31, 2021 · select a line to chart its full history

KLDO annual income statement
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
1.10M975.00K000
1.10M975.00K000
-87.67M-78.87M-86.66M-60.68M-27.03M
-90.29M-81.62M-86.33M-61.74M-27.56M
-2.16-2.44-3.36-12.09-6.17
KLDO annual balance sheet
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
40.63M48.38M73.53M78.27M28.68M
50.14M59.34M82.31M85.33M30.75M
39.53M38.85M33.42M28.34M21.93M
21.69M21.01M20.39M14.83M14.81M
10.61M20.50M48.88M-96.24M-43.68M
KLDO annual cash flow
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
-77.09M-61.52M-75.80M-46.32M-22.50M
-691.00K-4.02M-3.59M-3.00M-1.41M
70.04M40.40M74.64M98.91M49.74M
-691.00K-4.02M-3.59M-3.00M-1.41M
-7.75M-25.14M-4.74M49.59M25.84M